"UMC has continued to work with leading EDA companies such as Synopsys to make available to its customers high-quality solutions that pave the way to silicon success," said S. C. Chien, vice president of Customer Engineering & IP Development Design Support Divisions at UMC. "The qualification of Synopsys' proven StarRC parasitic extraction solution for UMC's 28-nanometer process technology strengthens the portfolio of resources available to our customers for 28-nanometer designs. Mutual customers can now take full advantage of our latest foundry processes and successfully bring their innovations to the marketplace."
StarRC is a key component of Synopsys' Galaxy(TM) Implementation Platform and the industry-leading parasitic extraction solution for system-on-chip (SoC), custom digital, analog/mixed-signal (AMS) and memory designs. StarRC's 28-nm features include modeling for key parasitic effects, including advanced retargeting effects, new via etch and coupling effects, area-dependent via resistance and capacitance, polynomial-based diffusion resistance, and enhanced layout-dependent device parasitic extraction. StarRC also offers other advanced capabilities for 28-nm designs, including unified Rapid3D technology for fast, high-accuracy 3D extraction, enhanced multicore performance and scalability, proprietary reduction capabilities and the smallest netlist for signoff of the largest SoC designs.
"StarRC continues to lead the industry in use for parasitic extraction and signoff of advanced node designs," said Antun Domic, senior vice president and general manager of Synopsys' Implementation Group. "UMC's validation of StarRC extends the benefits of our start-of-the-art process modeling and extraction technology to UMC's 28-nanometer customers, enabling them to deliver their high-performance 28-nanometer devices to market with increased confidence."